SARS-CoV-2 Is Linked to Brain Volume Loss in Multiple Sclerosis

Tomas Uher1, Dominika Stastna1, Ingrid Menkyova1,2

  • 1Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czechia.

Abstract

Insights

SARS-CoV-2 infection increased brain and spinal cord tissue loss in patients with multiple sclerosis (pwMS), particularly in those over 40. This study highlights potential long-term neurological effects of COVID-19 in pwMS.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Neuroimmunology

Background:

  • The neurological impact of SARS-CoV-2 infection on patients with multiple sclerosis (pwMS) is not well understood.
  • Investigating changes in brain and spinal cord pathology post-SARS-CoV-2 is crucial for managing pwMS.

Purpose of the Study:

  • To assess the effects of SARS-CoV-2 infection on brain lesion activity and volumes in pwMS.
  • To evaluate changes in spinal cord volume following SARS-CoV-2 infection in pwMS.

Main Methods:

  • 177 pwMS with confirmed SARS-CoV-2 infection underwent MRI scans.
  • Analysis focused on brain lesion load and brain/spinal cord volumes using mixed-effect models.
  • Patients were clinically stable, without disease activity or recent treatment changes.

Main Results:

  • SARS-CoV-2 infection did not alter brain lesion count or volume.
  • Significant whole brain, grey matter, and cortical grey matter volume loss was observed.
  • Ventricular enlargement occurred in pwMS over 40; reduced cervical cord area was seen in severe infections.

Conclusions:

  • SARS-CoV-2 infection is associated with increased neuronal tissue loss in clinically stable pwMS.
  • Age influences the extent of brain volume changes post-SARS-CoV-2.
  • Severity of SARS-CoV-2 infection correlates with spinal cord volume reduction.

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.4K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
686
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.4K
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
156
Brain Imaging01:14

Brain Imaging

Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans),  magnetic resonance imaging (MRI),  functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
323